Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Suzhou Zelgen Biopharmaceuticals Co Ltd patents


Recent patent applications related to Suzhou Zelgen Biopharmaceuticals Co Ltd. Suzhou Zelgen Biopharmaceuticals Co Ltd is listed as an Agent/Assignee. Note: Suzhou Zelgen Biopharmaceuticals Co Ltd may have other listings under different names/spellings. We're not affiliated with Suzhou Zelgen Biopharmaceuticals Co Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Suzhou Zelgen Biopharmaceuticals Co Ltd-related inventors


Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds

Deuterated diaminopyrimidine compounds, and intermediates thereof are described. In particular, disclosed are deuterated diaminopyrimidine compounds of formula (I), and pharmaceutical compositions containing such compounds or crystal forms, pharmaceutically acceptable salt, hydrates or solvates thereof. The disclosed deuterated diaminopyrimidine compounds can be used for treating and/or preventing protein kinase-associated diseases, such... Suzhou Zelgen Biopharmaceuticals Co Ltd

Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof

Disclosed are deuterated chenodeoxycholic acid derivatives and pharmaceutical compositions containing the deuterated chenodeoxycholic acid derivatives. In particular, disclosed is a deuterated chenodeoxycholic acid derivative of formula (I), or a crystal form, pharmaceutically acceptable salt, hydrate or solvate thereof, and a pharmaceutical composition containing the same. The deuterated chenodeoxycholic acid derivatives... Suzhou Zelgen Biopharmaceuticals Co Ltd

Deuterated quinazolinone compound and pharmaceutical composition comprising same

Deuterated quinazolinone compounds and pharmaceutical compositions containing such compounds are provided. In particular, deuterated quinazolinone compounds of formula (I) are provided, as well as pharmaceutical compositions containing such compounds or crystal form, pharmaceutically acceptable salts, hydrates or solvates thereof. The deuterated quinazolinone compounds of formula (I) can be used for... Suzhou Zelgen Biopharmaceuticals Co Ltd

Polymorphs of deuterated omega-diphenylurea or salts thereof

The invention relates to polymorphs of deuterated omega-diphenylurea or salts thereof. In particular, the invention provides polymorphs of 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl)-ureido]-phenoxy}-2-(N-1′,1′,1′-trideutero-methyl)picolinamide or its salt, namely, polymorphs of the compound as shown in formula (I) or its salt. The polymorphs are suited for preparing the pharmaceutical composition used for inhibiting phosphokinase (such as... Suzhou Zelgen Biopharmaceuticals Co Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Suzhou Zelgen Biopharmaceuticals Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Suzhou Zelgen Biopharmaceuticals Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###